• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma news

The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Caroline Richards on +44 (0)1959 563311 or email us.

 

Lilly’s CYRAMZA(R) (ramucirumab) receives third FDA approval

Posted on: 17 December 2014 | Source: Eli Lilly and Company

Eli Lilly and Company has received its third U.S. Food and Drug Administration (FDA) approval for CYRAMZA(R) (ramucirumab)...

Top 30 pharma companies spent $112 billion on research and development in 2013, says GlobalData

Posted on: 17 December 2014 | Source: GlobalData

The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous year, according to research and consulting firm GlobalData...

Selvita has raised PLN 27.3 MM on its way to the main market of the Warsaw Stock Exchange

Posted on: 17 December 2014 | Source: Selvita

Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has successfully completed its Initial Public Offering...

First trial of a novel oral anticoagulant starts in prevention of recurrent stroke due to a blood clot of undetermined source

Posted on: 16 December 2014 | Source: Boehringer Ingelheim

Boehringer Ingelheim announces that the first patient has been enrolled in the RE-SPECT ESUS™ phase III study to investigate the efficacy and safety of dabigatran etexilate for the prevention of recurrent Embolic Stroke of Undetermined Source, also called ESUS...

Cambridge structural database reaches 750,000 entry milestone

Posted on: 16 December 2014 | Source: The Cambridge Crystallographic Data Centre

Essential resource to scientists around the world reaches historic record...

Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

Posted on: 16 December 2014 | Source: Abbott

Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Notes Offer"), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due 2022 (the "Notes") issued by CFR International SpA...

Line dancing bacteria win the 2014 Dolomite and Lab on a Chip Video Competition

Posted on: 16 December 2014 | Source: kdm communications

The inaugural MicroTAS Video Competition, run by microfluidics specialist Dolomite and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society, saw first prize awarded to an enterprising – and highly creative – entry submitted by Tijmen Hageman from the Korean Institute of Science and Technology (KIST) Europe GmbH in collaboration with the Unviersity of Twente...

Pharma Webinar: Practical Application of RMM in Pharmaceutical Manufacturing

Posted on: 15 December 2014 | Source: Scott Sutton Ph.D. - President of Pharmaceutical Microbiology Forum & Owner of The Microbiology Network & Dr. Yongqiang Zhang - Senior Scientist at BD Diagnostics

Discussion on how a rapid method can provide a solution to a common microbiological testing problem for pharmaceutical manufacturers – process water microbiology testing.

Orange and USAID join forces to boost mHealth innovations across Africa

Posted on: 15 December 2014 | Source: Orange

The U.S. Agency for International Development and global telecommunications operator Orange announced a new alliance to develop innovations in mobile health (mHealth) at the Global mHealth Forum in Washington, DC...

UK patients with moderately to severely active ulcerative colitis gain access to a range of biologic therapies on the NHS

Posted on: 15 December 2014 | Source: MSD

NICE says ‘yes’ to REMICADE® (infliximab), HUMIRA® (adalimumab) and SIMPONI® (golimumab) for adult patients with moderately to severely active ulcerative colitis...

Abbott completes acquisition of Veropharm

Posted on: 15 December 2014 | Source: Abbott

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer...

Biotech-Cluster Rhine-Neckar (BioRN) leads InnoLife consortium to success in the competition Healthy Living and Active Ageing of the European Institute for Innovation and Technology (EIT)

Posted on: 15 December 2014 | Source: BioRN

Future role as German coordination centre for the largest European cooperation project in the health sector to date...